Stay Ahead of Market & Policy Shifts
Financial & Policy Research Insights
Consumer Staples: Risks From Anti-Obesity Medications Likely Overblown
Fundamental, Research
Anti-obesity medications (AOMs), including glucagon-like peptide-1 (GLP-1) agonists...
Read moreAmazon: $7+ EPS by 2025 Could Be the Next Catalyst
Fundamental, Research
Wall Street has historically valued AMZN shares using nontraditional relative valuation metrics.
Read moreETF Trends to Watch in 2024: Part 1
Other, Research
The Exchange Traded Fund (ETF) industry in the U.S. had a strong 2023, setting...
Read moreEnergy: Venezuela Eyes Exxon Mobil’s Crown Jewel
Fundamental, Research
Venezuela’s President Maduro recently held a referendum over potentially annexing...
Read moreTech Software: The Roadmap to GenAI Adoption
Fundamental, Video
Generative AI (GenAI) has gained significant market...
Read moreHong Kong Investment Property: Retail Is a Bright Spot Amid Dismal Office
Fundamental, Research
Hong Kong’s tourist arrivals and retail sales have picked up since...
Read moreLowry Weekly ETF Commentary, December 8, 2023
Research, Technical
In recent weeks, there have been several indications of increased participation...
Read moreAPAC Tobacco: Limited Contributions from Reduced-Risk Products
Fundamental, Research
Despite increased adoption of reduced-risk products (RRPs) since 2014...
Read moreLowry Weekly Sector Commentary, December 05, 2023
Research, Technical
The landscape of the sectors has undergone significant changes since...
Read moreHoliday Outlook – Apparel & Footwear Retail
Fundamental, Video
American consumers have shown remarkable resilience in 2023 despite the challenges...
Read more